Iradimed 

$83.47
26
-$3.13-3.61% 19:37 Today

Statistics

Day High
86.53
Day Low
83.35
52W High
105.15
52W Low
68.55
Volume
2,613
Avg. Volume
-
Mkt Cap
1.07B
P/E Ratio
53.11
Dividend Yield
0.92%
Dividend
0.77

Upcoming

Dividends

0.92%Dividend Yield
Aug 26
$0.20
May 26
$0.20
Mar 26
$0.20
Dec 25
$0.50
Nov 25
$0.17
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
16.67%

Earnings

29OctExpected
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Next
0.41
0.46
0.5
0.55
Expected EPS
0.545
Actual EPS
N/A

Financials

26.82%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
83.81MRevenue
22.48MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow IRMD. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
GE Aerospace
GE
Mkt Cap355.45B
General Electric, through its healthcare division, offers a range of medical imaging, patient monitoring, and life care solutions that compete with Iradimed's MRI-compatible IV infusion pump systems and patient monitors.
Koninklijke Philips N.V.
PHG
Mkt Cap26.12B
Philips is a diversified technology company that provides various health tech solutions, including patient monitoring systems that compete with Iradimed's products.
Medtronic
MDT
Mkt Cap116.77B
Medtronic offers a wide range of medical devices and technology, including patient monitoring systems, that directly compete with Iradimed's offerings.
Boston Scientific
BSX
Mkt Cap67.88B
Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties, including areas where Iradimed's products are used.
Smith & Nephew
SNN
Mkt Cap12.12B
Smith & Nephew specializes in medical equipment for surgery, including devices for minimally invasive procedures, which can be seen as complementary or competitive to Iradimed's product lines.
Stryker
SYK
Mkt Cap126.84B
Stryker Corporation specializes in medical technologies, including surgical equipment and neurotechnology products that can compete with Iradimed's offerings in certain clinical settings.
Zimmer Biomet
ZBH
Mkt Cap19.25B
Zimmer Biomet Holdings, Inc. focuses on musculoskeletal healthcare. Their products for surgical solutions can indirectly compete with Iradimed's infusion systems and patient monitors in the operating room.
Abbott Laboratories
ABT
Mkt Cap194.62B
Abbott Laboratories offers a broad range of medical devices, diagnostics, and nutrition products that can compete with Iradimed in the broader healthcare and medical device market.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson, through its medical devices segment, provides a wide range of products that compete in the healthcare market, including areas relevant to Iradimed's focus.
Intuitive Surgical
ISRG
Mkt Cap131.63B
Intuitive Surgical, Inc. specializes in robotic-assisted, minimally invasive surgery systems that could be used alongside or in competition with Iradimed's patient monitoring and infusion products in surgical settings.

About

iRadimed Corp develops, manufactures, markets, and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system, which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates the majority revenue from United States.
Show more...
CEO
Roger E. Susi
Employees
166
Country
United States
ISIN
US46266A1097
WKN
000A118V4

Listings

0 Comments

Share your thoughts

FAQ

What is Iradimed stock price today?
The current price of IRMD is $83.47 USD — it has decreased by -3.61% in the past 24 hours. Watch Iradimed stock price performance more closely on the chart.
What is Iradimed stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Iradimed stocks are traded under the ticker IRMD.
Is Iradimed stock price growing?
IRMD stock has fallen by -4.14% compared to the previous week, the month change is a -10.38% fall, over the last year Iradimed has showed a +15.7% increase.
What is Iradimed market cap?
Today Iradimed has the market capitalization of 1.07B
When is the next Iradimed earnings date?
Iradimed is going to release the next earnings report on October 29, 2026.
What were Iradimed earnings last quarter?
IRMD earnings for the last quarter are 0.46 USD per share, whereas the estimation was 0.44 USD resulting in a +4.55% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Iradimed revenue for the last year?
Iradimed revenue for the last year amounts to 83.81M USD.
What is Iradimed net income for the last year?
IRMD net income for the last year is 22.48M USD.
Does Iradimed pay dividends?
Yes, IRMD dividends are paid quarterly. The last dividend per share was 0.2 USD. As of today, Dividend Yield (FWD)% is 0.92%.
How many employees does Iradimed have?
As of September 04, 2026, the company has 166 employees.
In which sector is Iradimed located?
Iradimed operates in the Health & Wellness sector.
When did Iradimed complete a stock split?
Iradimed has not had any recent stock splits.
Where is Iradimed headquartered?
Iradimed is headquartered in ORLANDO, United States.